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ACCEPTABILITY OF FIRST TRIMESTER MEDICAL ABORTION

Recent scientific discovery and clinical investigation have opened a new world of medical
abortion. As a result, there has been an explosion of scientific, public, and political interest in the
promise and problems of this technology. While some have predicted a medical utopia of easy,
effective, safe, and accessible abortion services, others have raised caution in language ranging
from skeptical to downright hostile. Questions have been raised about safety, efficacy, and
feasibility in various cultural and clinical contexts, and also about the extent to which women
would use medical methods of abortion. In fact, like Coronado searching for the gold-paved
streets of the Seven Cities of Cibola, we are likely to find, instead of utopia, a landscape of
considerable interest and great potential whose riches are more nuanced and subtle than at first
predicted.

I.

Aspects of Acceptability in Abortion Services
For a new medical technology to become widely used, it must be acceptable to the

consumers and the providers of medical services and be feasible to administer within the health
service delivery environment. As with consumer goods, acceptability is much more important with
more elective procedures. Contraception and induced abortion are two areas in which consumer
preference may be especially salient, since most of the services are both elective and provided to
healthy patients. The problem of defining acceptability research was first confronted in regard to
the development of contraceptive technology and family planning services. Concepts of
acceptability have been evolving since the mid-1970's and have been applied to the study of
medical abortion in scattered studies over the past fifteen years. Before reviewing the information
developed by those studies, it is helpful to review the meaning of acceptability and acceptability
research.
Acceptability research takes place at the unmarked crossroads where clinical,
psychological, and marketing research intersect. Studies generally bear the flavor of the
academic training of the researcher conducting the work. "Acceptability" was defined initially by
the World Health Organization (WHO) as "a quality which makes an object, person, event, or idea
attractive, pleasing, or welcome" (Marshall, 1977). In fact, acceptability research has been not
only about qualities of various technologies but about perceptions, attitudes, and behaviors of
people as well. Rather than being a quality, acceptability is an interaction between or product of
(a) the values of individuals and (b) their perceptions of the attributes or qualities of particular
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products. This approach, combining values and perceived characteristics, was employed in a
study of perceptions of family planning services (Severy and McKillop, 1990) who note that "the
combination of valued and perceived features of family planning services may be viewed as the
reasons for women's choice."
Values are universal, prized characteristics that individuals seek in the products or
services they choose, even as they acknowledge that all desirable values may not be represented
in one product. The attributes of specific products, some tangible and verifiable and others in the
eye of the beholder, can then be matched by individuals against their ideals. Insofar as the
attributes of a technology are perceived to correspond or lead to valued outcomes, these products
will be desired, preferred, or "acceptable."
Whatever affects either values or perceptions can, therefore, affect acceptability. Factors
highly likely to be influential in shaping values and perceptions include:
•

ethnicity/nationality/culture

•

class/education

•

personality

•

experience

Perceptions are also influenced by the objective reality of the item being evaluated and
the alternatives in the environment with which one might compare it. Medical technologies do,
indeed, have different objective characteristics whose value is modified by the range of
alternatives available in the local health service environment.
Previous research on contraception and abortion suggests some of the values that
appear repeatedly as important components of acceptability (David, 1992; Winikoff, 1992):
•

Efficacy - The desire for induced abortion represents an attempt to solve a
particularly difficult and stressful problem: unwanted pregnancy. There is,
logically, a high value placed upon a method that will effectively terminate the
pregnancy.

•

Safety/Freedom from Side Effects - This is highly valued in virtually all medical
and surgical interventions and particularly in contraception and abortion, since
patients are healthy, young, and perhaps anticipating future reproduction.

•

Freedom from Pain - This is a self-evident preference, one strongly held in many
populations. It becomes particularly important when there are alternatives that
differ with respect to anticipated pain.

•

Ease/Convenience - This can refer to the accessibility of the services or to the

2

troublesomeness of the method itself. Many women seeking abortion have
household, child care, or employment obligations that they do not wish to disrupt.
More generally, this value may refer to the desire to cause minimal inconvenience
in one's life.
•

Gentleness/Non-invasiveness - This may relate to anticipated pain but also
refers to preserving bodily integrity, and a preference for techniques that will be
less physically aggressive. With respect to abortion, therefore, it may also have a
connotation of "more moral."

•

Privacy - Women are particularly concerned with privacy when dealing with a
problem related to sexual behavior and intimate relationships. There may also be
needs for secrecy because of the real or presumed disapproval of partners,
family, or society in general. Physical privacy, as in protecting one's body from
exposure to strangers in a threatening environment, may also have a high value.
Thus, the characteristic labeled "privacy" may have several different meanings
which may attach positively and negatively to various abortion techniques.

•

Autonomy - Some women appear to value very highly the ability to make
decisions concerning their lives and bodies and to manage the processes that act
upon or derive from their physiology. Methods associated with loss of
consciousness may be particularly unwelcome to such women.

•

Affordability - This is a key ingredient in the acceptability of many consumer
items. It has been less often studied with respect to medical technology, because
treatment is generally provided free in clinical investigations. Cost is, of course,
an issue when products become available for purchase. Certainly affordability
affects provider, program manager, and policy maker acceptance of new
technologies.

How medical abortion "fills the bill" or corresponds to these values is determined by
women's perceptions of the characteristics of the technology. Perceptions of the attributes of a
method are strongly influenced by personal, community, and medical characteristics and also are
influenced by which other methods are offered and what kinds of service delivery requirements
surround those methods. Studies of medical abortion have, in fact, assessed very different
regimens as technology has evolved. Drugs have included antiprogestins and prostaglandin
analogues, both separately and in combination. The route of delivery has varied, including oral,
vaginal, and intramuscular administration, and side effects have ranged from minimal to extremely
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distressing. In addition, service delivery variables are not constant: some women are treated as
inpatients, others as outpatients, and still others are self-treated at home. These differences may
have very large impact on the perception and acceptability of the characteristics of the methods.
In clinical practice, the alternative surgical abortion options may also have variable
characteristics. For example, vacuum aspiration can be provided as an inpatient or outpatient
procedure and can be carried out under general or local anesthesia. Individuals must thus assess
the characteristics of medical abortion against an alternative that is variable from study to study.
Clinical research has shown that regardless of which drugs or procedures are used, the
following characteristics appear to be true intrinsic characteristics of existing medical abortion
regimens, as compared to surgical abortion:
•

a slightly lower efficacy

•

a longer procedure from initiation to completion of abortion

•

more consciousness on the part of the patient of bleeding and of the expulsion of
products of conception

•

more difficulty in combining the procedure with other desired procedures for
fertility regulation (e.g. IUD insertion, sterilization)

If patients object strongly to these attributes, the method may be rejected. Improvements can only
come with new advances in technology.
Several other characteristics that might at first appear to be intrinsic to the method are, in
fact, dependent on service delivery choices. These include:
•

more visits than for surgical abortion

•

more or less pain than surgical abortion, depending on the type of anesthesia
used in surgery and the dose and type of prostaglandin used for medical abortion

•

II.

no admission to hospital

How is Acceptability Studied?
"Acceptability" can be examined in several ways (Winikoff, et al., 1992). Useful concepts

include:
•

primary acceptance (whether the method would be used if offered, regardless of
alternatives)

•

comparative acceptance (a test of the uptake of a technology in the context of
other available choices to see which one(s) are preferred)

•

re-use/recommendation (whether individuals, having used the technology, would
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use it again and/or recommend it to others)
•

side effects/complaints (stated negative aspects indicating reasons—occasionally
powerful ones—that people might avoid a technology)

All of these issues can be studied through a series of questions oriented to the potential
user as a consumer of an offered product:
•

Will (would) you use (or prefer) it?

•

Why (or why not)?

•

Did you find its use satisfactory?

•

Why (or why not)?

•

Would you use it again (or recommend it to others)?

•

How does it compare to previous experience with other technologies?

These questions form the basis of assessment of acceptability. They suggest study
designs that rely heavily on interviews with users both before and after the experience of medical
abortion. This provides information on what users think of the product's attributes before and after
use, as well as whether experience is consonant with expectations, and if evaluation of the
characteristics, benefits, or drawbacks of medical abortion changes after use. While eliciting
information through patient interviews is common to all acceptability studies, other methodological
issues in study design are quite variable.
Researchers studying acceptability need to decide not only when to assess acceptability
but also how to design the studies that offer experience with the new technology. There are
several methodological problems that loom large in this endeavor.

A.

To Compare or Not to Compare ?
To those who perform clinical trials, a comparative trial always seems a fairer and more

scientific test. While this may be so usually, there are certain disequilibria in any comparison used
to assess a new technology. Generally, a comparative trial of new technology tests an unknown
method against a fairly well-known method. This means that both users and providers may have
well-formed ideas about the risks, benefits, and characteristics of the more standard method but
perhaps nebulous or erroneous impressions of the new technology. Personal biases, rumor, and
fantasy may have more impact on attitudes about the new method than about the better-known
technology. In addition, providers may give very realistic and specific information about
characteristics of the usual procedure; they may not be able to provide as accurate counseling
about the newer one. This may create bias in choice or excessively high or low expectations of
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the newer method. Users' attitudes about newness and risk-taking in general may become more
important in both method choice and method evaluation.

B.

To Randomize or Not to Randomize?
Classical trials of drug therapy rely heavily on random allocation of patients into groups,

comparing, for example, the best available therapy and a new therapy. The ideal is a double blind
study in which neither patient nor prescriber knows which drug is received. Side effects and
efficacy of the two therapies are then compared appropriately. This "experiment" will identify which
of two methods would be more acceptable if a similar population of patients were to be assigned
to a method. The equivalent of this situation would occur if a health service needed to choose
only one technology to offer for first trimester abortion.
On the other hand, patients who elect one procedure from alternatives presented are likely to
be different from a random sample of the population. Distinct characteristics of each method will
preferentially attract a different group of users. Thus, the results of a random allocation trial may
not represent the reactions of the women most likely to use the method once it becomes available
as a choice.
Randomization, of course, means that women who enroll in a study must be willing to accept
any of the procedures in the trial. If a woman has an aversion to one of the study methods, she
will not enroll in the study at all for fear of being assigned to a treatment she could not accept.
Such refusals of treatment have occurred in random allocation studies (Rosen, 1984), indicating
that randomized study populations do not represent the full range of women who will be
candidates for the methods under study.

C.

A Study is Always a Study
The study context is, itself, distorting; there is always an effect of the research process on

the research results. The study context serves as a filter for the types of people who enroll and,
therefore, affects the representativeness of the group being studied. A person who volunteers for
a study needs to be willing to tolerate the extra burden of the study. Such persons also may be
willing to accept more onerous regimens and may not reflect the dissatisfaction that
inconveniences of various methods would elicit in a general population.
Those who choose to enter the trial may be especially averse to some feature of the
standard method or especially excited by some aspect of the new method, since they could get
standard treatment without being in a study. If subjects choose among several methods, those
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who choose to be in a study of the standard method may be very different from the general
population of users of that method: for some reason they have enrolled in a study when they could
receive the same method without doing so. Finally, study conditions sometimes impose many
more visits than would be necessary in a normal clinical situation. This can also affect
acceptability.
It is tempting to believe that the attitudes of patients with prior abortion experience are an
especially good test of acceptability of new methods as the same user can rate two different
technologies. However, such women usually have experienced surgical abortion, and those
among them who opt for medical methods in trials may have been especially dissatisfied,
disappointed, or unhappy with the results. Thus, again, the cohort of women who choose to enter
a study of medical abortion (if it is the only alternative) or who choose medical abortion in a
comparative study may be quite different from the general population of women who have had an
abortion before.

III.

Studies of User Acceptability
The existing literature on acceptability of medical abortion is, in fact, quite small. Since

1979, 12 published studies have evaluated the acceptability of medical abortion methods in the
first trimester (Table 1). Altogether the work was carried out in seven cultural environments, none
in developing countries. In addition, the number of patients in each study is generally quite small.
Only one study has cohorts of greater than 100 patients.
As medical abortion regimens have evolved, the methods studied have changed in
important ways. Because of the variability in methods studied, there is a wide range of side
effects and, therefore, patient reactions. The two earliest studies used prostaglandin vaginal
suppositories alone. Later, mifepristone (RU486/Roussel Uclaf) was used alone or in combination
with a prostaglandin. The prostaglandin was variously administered vaginally, intramuscularly, or
orally. A combination of oral mifepristone and a vaginal suppository was evaluated in eight
studies; mifepristone plus injectable prostaglandin in one; mifepristone plus oral prostaglandin in
one other; and mifepristone alone was studied in two.
Of the 12 studies, two were of one method only, five involved patient choice of medical
abortifacient, four involved random allocation, and one used both patient choice and random
allocation. Only seven of the 12 studies report on regimens that are approved for regular clinical
use, and most of these used vaginal suppositories as the vehicle for prostaglandin.
Eligibility was restricted to patients with very early pregnancies (≤42 days) in two studies.
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Three studies allowed enrollment to 49 days; two studies up to 56 days; and four studies through
63 days of amenorrhea. One study only states that the women requested a medical abortion in
very early pregnancy. Since the experience of medical abortion can be quite different for patients
at the extremes of these ranges, reactions and acceptability may have been affected. There were
also varying exclusion criteria, producing groups with both unknown and obvious biases. For
example, Rosen, et al., studied only women who had complete abortions (1979) or prior deliveries
(1984). Grimes, et al. (1992), studied women without a pregnancy test, half of whom turned out
not to be pregnant.
The number of visits required of patients was also very different from study to study;
some studies required as few as two visits for a medical abortion, and two studies required seven
(Tang, 1991; Holmgren, 1992). The number of interviews varied as did their timing relative to the
treatment (Table 2).
Yet, because of very strong consistent findings under such variable circumstances, these
studies provide clear general conclusions about factors affecting the acceptability of medical
abortion services (Table 2).
Pioneering work in this field was developed by Rosen and her colleagues in Sweden
(1979; 1984; 1990) who designed studies to test acceptability in patients randomly allocated to
vaginal prostaglandin or vacuum aspiration. The hospital was well known for its work on medical
abortion and, thus, attracted patients interested in that method. Even the random allocation of
patients may not have been able to control for this bias.
In the earlier study (1979), the first 30 patients using each method who had complete
abortions were evaluated. This design meant, of course, that failure as a reason for method
dissatisfaction was not registered. Differentials in success rates were thus eliminated as possible
reasons for preference of one method over another.
Prostaglandin treatment was, by far, the preferred method in both medical and surgical
treatment groups. Women treated with medical abortion increased their preferential rating of it
after the abortion and valued the naturalness of the method and privacy during treatment.
However, they gave negative evaluations regarding pain and the duration of treatment. They also
reported more bleeding.
The most striking finding of the study was the enormous increase in the acceptability of
surgical abortion among surgical patients. They appreciated a quick and painless procedure.
After treatment, most of the patients in this group switched to a preference for vacuum aspiration.
Women in both groups were positive about the hypothetical possibility of a self-administered
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method. Women in the prostaglandin group became even more positive toward such a possibility
after the experience of medical abortion.
A later study (1984) compared surgical abortion to both medical abortion in the hospital
clinic and medical abortion at home. A specific intent was to assess acceptability of a home
abortion remedy. Initially, home treatment was a stated preference of 69%, and medical methods
were preferred by 84% of the women enrolled. In fact, when the study was randomized, four
patients found their assigned method to be so unacceptable that they withdrew from the study and
changed methods. Of these women, two switched out of home treatment (one each to hospital
prostaglandin and vacuum aspiration) and two switched into home treatment (one from the
hospital prostaglandin and one from the vacuum aspiration group).
Success rates were high for both treatments (97% for medical abortion and 100% for
surgical), but duration of bleeding was longer for the medical group (about double the number of
days). There was also a substantial incidence of vomiting and diarrhea in the medical group;
neither of these side effects occurred in the vacuum aspiration group. Analgesic injections were
required by 39% of the prostaglandin hospital treatment group but only 6% of the home treatment
group. No surgical patients required analgesia after the dose given at surgery. Women did not
change their positive attitudes toward medical abortion after their experience of it. The truly
striking finding was the extent to which vacuum aspiration patients became very positive in their
evaluation of the surgical method.
In a summative evaluation of the two studies (Rosen, 1990), 81% of patients who
experienced prostaglandin treatment had preferred medical abortion initially and 78% preferred it
after treatment. Among vacuum aspiration patients, however, while only 38% preferred surgery
before treatment, 69% preferred it after the experience. Most patients stated that they would
select the method that they had used if they needed a repeat abortion and would recommend it to
others. This preference was slightly stronger among the medical group (75% to 68%). On the
other hand, a slightly larger number of women in the medical group (16% versus 13%) said that
they would prefer and recommend the method they had not used.
Most of the medical abortion users who switched preference did so because of pain
and/or amount or duration of bleeding. Some reacted negatively to the length of the procedure. A
substantial portion (31%) of the surgical patients persisted in a preference for medical treatment,
because it was more natural, involved less risk of infection, and required no hospital admission.
Surgical patients who preferred surgery cited a quick, easy procedure with no pain.
Hill, et al. (1990), studied 100 women using mifepristone plus a vaginal suppository. Of
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interest is that only 64% of the women offered the method agreed to try it instead of the routine
surgical abortion. About half of those who declined ascribed their reluctance to the length of the
trial and the required follow-up, and about half stated that they would prefer to be asleep during
the procedure. Eighty-eight percent of the women interviewed after the procedure would use the
method again; 9% would not, while 3% remained unsure. Of the 9% who would not, one-third
were dissatisfied because of method failure, and two-thirds claimed that the method had been too
painful. All 18 patients with previous surgical abortion experience preferred the medical abortion.
In a 1991 study, Tang reported on a trial of mifepristone plus vaginal prostaglandin
suppository versus surgical abortion. Women were allowed to choose their method, and the final
sample included 23 who chose a medical abortion and 19 who chose vacuum aspiration.
Reasons given for choosing medical abortion included that it would produce less trauma to the
body (38%), it was a more natural means (22%), or patients perceived physician preference for
the method (13%). Fears about aspects of surgery were also prominent: fear of pain (11%), fear
of general anesthesia (5%), and rejection of hospitalization (9%). The women in Tang's study
who said that medical abortion was easy referred to the ease of taking medication as compared to
hospitalization and surgery. Nonetheless, most were not favorably disposed toward the idea of
using a medical method at home. Reasons given for not choosing medical abortion were worries
about efficacy or side effects (28%), the length of the abortion procedure (18%), or desire to get
the abortion over quickly (16%). Almost two-thirds of the patients who were requesting a repeat
abortion chose to use surgery a second time rather than switch to medical abortion.
Reactions to the medical therapy were assessed at three points in time. At each
assessment, a substantial number of patients (30-50%) expressed their relief or stated that they
felt good. At 43 days after treatment, patients liked the medical therapy because it was "natural"
or like menstrual regulation (39%). Negative comments included that the bleeding was too long
(11%) and that the visits were inconvenient (9%). (This study's protocol for medical abortion
required seven visits.) Almost all women experiencing medical abortion (96%) would recommend
it to friends. Two of the 23 medical abortion patients would not use it again. These two were not
among the three method failures. In the surgical group, all women said they were satisfied with
their method.
Single women found mifepristone more convenient as it did not require an overnight stay,
and they could go to work as usual. Thus, they would not have to explain an absence at home or
at work and could keep the abortion secret. These women also were afraid surgery might have
an effect on their future fertility. Married women, on the other hand, often chose surgery because
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child care obligations meant they could not afford the time for the treatment schedule of the
medical abortion, and they did not have as many worries about future fertility. In addition, the
authors speculate that experience of childbirth may have made surgical intervention more
acceptable.
Tang and colleagues (1993) extended this work in a second study, enrolling 144 women
of whom 99 (69%) chose medical abortion with mifepristone plus prostaglandin vaginal
suppository and 45 (31%) chose vacuum aspiration. Younger, single, and nulliparous women
preferred the medical method. Reasons for choice of the medical method were remarkably similar
to the previous study, including: fear of surgery (81%) or general anesthesia (11%), less injury to
body (21%), and convenient for work (41%). Surgery was preferred because it was quick and
convenient (82%), and patients did not like the number of visits or length of the medical abortion
process (69%) or were worried about drug efficacy and side-effects (11%).
Almost all the women who tried medical abortion would use it again (85%), including four
of the 12 women for whom the method had failed. Of the 27 women who used medical abortion
and had previous experience of surgical abortion, 70% felt that medical abortion was better. At
the final evaluation (43 days after treatment), the most common reactions were relief (38%) and
complaints that the procedure took too long (11%) or that there was too much bleeding (10%).
Urquhart and Templeton (1991) assessed psychiatric morbidity and acceptability following
medical and surgical abortion. The medical abortion method was mifepristone followed by a
vaginal prostaglandin suppository. The medical abortion patients chose their method, but surgical
patients were recruited from the usual clinic patient population. The clearest finding of this study
is a large decrease in anxiety and depression after successful abortion using either method.
When asked if the same method would be acceptable again, 75% of the medical abortion
and 94% of the surgical patients said yes. Women tended to be less positive toward medical
abortion if they were younger, nulliparous, had a failure or problems with the procedure or saw the
products of conception. Patients cited as positive features: awareness of what was happening,
feeling more in control, a more natural and more discreet method, and no anesthesia. Of the 13
women who had a previous abortion, 77% said that they preferred the medical alternative.
This is the one study that shows not only an improvement in attitude toward surgical
abortion but a higher preference for it among the patients in the surgical group than for medical
abortion among the medical abortion patients. This may be due, in part, to study design. Patients
experiencing medical abortion were recruited for a clinical trial, whereas the vacuum aspiration
patients were recruited after having experienced the usual medical service. The patients using
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medical abortion might have had higher expectations for the new treatment under study. These
differences may have meant that the composition of the two groups was not comparable or that
there were substantial differences in the experience of treatment. Nonetheless, in both groups,
the large majority of the women were satisfied and would use again the treatment they had
experienced.
Legarth, et al. (1991), conducted a random assignment study in Denmark using surgical
abortion with general anesthesia and mifepristone alone. Mifepristone patients reported both
longer persistence of pain and higher pain scores as well as longer bleeding than the vacuum
aspiration patients. However, women who experienced uncomplicated medical abortion spent
fewer days in bed than women who experienced an uncomplicated vacuum aspiration. Both
groups rated their method as acceptable, but the mifepristone group "evaluated the procedure
more positively." Four women in the mifepristone group had had previous abortions, and all
preferred the medical procedure.
One unusual feature of the study is a high rate of serious complications. Three of 25
vacuum aspiration patients developed Pelvic Inflammatory Disease (PID), and another had a
uterine perforation requiring emergency laparotomy. Six of 25 mifepristone patients had
incomplete abortions treated by surgical evacuation, three of whom developed PID. Even with
such high failure and complication rates, women found the procedure acceptable.
Holmgren's 1992 report documents an interview study of women who underwent either
vacuum aspiration (40 women at 5-8 weeks of pregnancy), dilatation and aspiration with heavy
sedation (43 women at 9-12 weeks of pregnancy), or medical abortion with mifepristone and
gemeprost vaginal suppository (45 women who had volunteered for studies in "very early
pregnancy"). The women were interviewed about the acceptability of the abortion experience
about two weeks after treatment. The large majority of women gave a positive evaluation of the
experience: 88% of those using early vacuum aspiration, 72% undergoing later dilatation and
vacuum aspiration, and 87% experiencing medical abortion.
Medical abortion patients reported more pain and evaluated the blood loss as heavier
than did the women who experienced surgery. Nonetheless, 40% of the medical abortion patients
noted their relief not to have needed a surgical procedure. As in the other studies of this type,
most women (70-80%) reported that, if another abortion were necessary, the same method would
be preferred.
Bachelot, et al.'s 1992 study is the only one that compares the acceptability of nonexperimental methods in a general clinic population. It reports on the choices of nearly 500
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women who came for abortion in six French clinics. The available choices for women requesting
early abortion were medical abortion (mifepristone, then intramuscular prostaglandin), vacuum
aspiration under general anesthesia, and vacuum aspiration with local anesthesia. Amenorrhea
had to be 42 days or less at enrollment in order for all of the interviewed women to be eligible for
medical abortifacient treatment by 49 days, including the one week waiting period required by
French law.
Women's initial choices favored the medical method (64%). Some women expressed no
preference among the methods offered. After women consulted with physicians, the procedures
performed were medical abortion, 59%; vacuum aspiration with local anesthesia, 31%; and
vacuum aspiration with general anesthesia, 11%. Generally, women who elected the medical
method or surgery with local anesthesia had higher educational levels, higher occupational levels,
and were more often from North American or European ethnic/cultural backgrounds. More of the
women who initially had no preference or preferred general anesthesia came from Africa and
South America.
Eighty-six percent of the women were later interviewed to learn their impressions of the
characteristics and acceptability of the methods. Valued characteristics most significantly
associated with medical method selection included:
• newness of the method
• efficacy of the method
• less invasiveness
• possibility of seeing the expulsion
• "naturalness" of the method
Women who elected vacuum aspiration tended to value the guarantee of medical
precautions, the waiting period, and a method of proven reliability. Substantial proportions of
women in all the groups placed high value on methods that were less traumatic, less dangerous,
more effective, and safer for future pregnancies but assigned these qualities to different methods.
The possibility of failure was less important among those who chose the medical method and
avoidance of trauma less important among those who chose vacuum aspiration under local
anesthesia. Worry about risk for future pregnancy was more important for women who chose
medical abortion.
Most of the women who chose the medical method of abortion knew that they would
choose this method before they arrived at the clinic (68%). Surgical patients only half as
frequently had a preference for surgical abortion before arrival at the clinic. Women who used the
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medical abortion method were characterized by wanting to see what was expelled and a desire to
control the situation that they were encountering. They also expressed the need for more rest
after the procedure.
At interview, most women in all groups expressed satisfaction with their chosen
experience. There were more expressions of dissatisfaction, however, among the medical
abortion group (12%) than the surgical group (4%). The authors note that women appeared to
have heard about the new method as a "magic one," but later felt the abortion was "not so easy
and quick" as they had been expecting. Satisfaction decreased where abortion was unsuccessful
and more side effects were recorded. It is noteworthy that the rate of follow-up in the groups was
fairly different: 94% of the medical abortion patients returned for interview, but only 78% of the
vacuum aspiration/local anesthesia and 71% of the vacuum aspiration/general anesthesia did so.
It is possible that women less satisfied with their treatment in the latter groups did not return for
the extra visit. This would affect the differential in recorded dissatisfaction among the methods.
In order to take account of patient preference for method of abortion in study design,
Henshaw and colleagues (1993) carried out a study that combined both patient choice and
random allocation between medical (mifepristone followed by prostaglandin vaginal suppository)
and surgical (vacuum aspiration under general anesthesia) abortion methods. Women who were
eligible for both methods were asked if they were willing to be randomly assigned a method, and
those who were not were given their choice of technology. Most women were apparently willing to
cooperate with the initial suggestion of random assignment and were allocated to medical (27%)
or surgical (26%) treatment. Those who declined to be assigned a method had a strong
preference for one or the other: surgical abortion, 26%, and medical abortion, 20%.
Women who chose surgery lived significantly further from the clinic, and this may have
affected their method choice because of the extra visits required for the medical procedure.
Medical abortion was assessed as "too slow" by 40% of the women who chose surgery, and 39%
preferred to be unconscious during the procedure. Some (23%) also feared adverse physical
effects from a medical procedure. Those who preferred the medical procedure expressed fear of
surgery or anesthesia (59%), felt medical abortion was "more natural" (21%), and that surgery
was "too fast" (21%).
Acceptability was similar and extremely high in both medical and surgical abortion
patients who chose their method. Only 4% of each group would certainly choose the other
method if another abortion were necessary; 95% of medical patients and 90% of surgical patients
would choose the same method again. Vacuum aspiration (under general anesthesia) was rated
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as less painful, but in all other aspects the two methods were rated equally.
This was not true of the women assigned a method. Among these women, medical
abortion ranked lower on six of 12 features. Most women would choose the same procedure
again, but the rates were lower than for those who chose their method and lower for the medical
(74%) than for surgical (87%) group. Gestational age was the only predictor of dissatisfaction
among women assigned to medical abortion: 95% of those who rated the procedure unacceptable
had had the abortion at 50 or more days' gestation. At earlier gestational ages, there were no
differences in acceptability among the women allocated randomly to medical or surgical abortion.
Conversely, gestational age did not have any impact on acceptability among the women
who chose their own method of abortion. The authors recommend that eligible women who
express a preference for method of abortion be accorded their choice regardless of length of
gestation. The study demonstrates both the importance of existence of choice for women with
different preferences and the fact that the process of choice may be associated with higher overall
satisfaction.
It is interesting to speculate on how many women might have expressed a preference for
a method if the first option presented had been choice rather than random assignment. In a
slightly different study design, women eligible for both methods were give a choice and only those
who were undecided were randomly assigned a method (Winikoff, et al.). In this study of over
1000 patients in three countries, only 1% of patients did not express a preference between
medical and surgical abortion and were therefore assigned a method.
Thong and colleagues (1992) in Scotland studied 180 women choosing medical abortion
to determine preferences in aspects of service delivery for this technology. The women were
apparently participating in another study as well, since they received one of four different doses of
mifepristone followed by either vaginal suppository (52%) or oral misoprostol (48%). Route of
administration of prostaglandin does not appear to have been by patient choice. Efficacy of the
regimens with the two prostaglandins was similar (94/95%), but patients using vaginal
suppositories required more and stronger pain relief.
Place of treatment with the prostaglandin was randomized to a sitting-room with
outpatient atmosphere or a more formal hospital admission to a ward. Women were interviewed
about their experience prior to discharge. Most women would have preferred treatment in the
sitting-room (77% of those assigned there and 69% of ward patients). Admission at the same time
as other women, to either setting, appeared to strengthen the stated preference for sitting-room
treatment. Virtually all the patients were satisfied with their medical abortion experience—one
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woman was "unsure"—and 85% would recommend it to a friend. All 41 of those who had had a
surgical abortion previously were satisfied with the medical regimen.
This work provides evidence that individualized options need to be available in several
dimensions. Some women in the sitting-room wanted to lie down, so some provision for this was
needed. About half of women would have wanted a partner or friend with them, but a slightly
larger group did not want anyone. It should be possible to accommodate both preferences. One
quarter of the women expressed preference for a home abortion, an option that is not yet
available.
Grimes and coauthors (1992) report on a different sort of acceptability study. They
enrolled women interested in medical abortion, in a randomized manner, to use mifepristone
alone or a placebo in very early pregnancy. The delay in expected menses could be no more than
10 days, and there was no pregnancy test prior to enrollment. In effect, this study tested a
medical version of "menstrual regulation." Effectiveness was clearly documented to be higher
with mifepristone than with placebo but side effects did not differ. In fact, two of four women who
were pregnant and received drug reported passing tissue as did two of four women who were not
pregnant and received placebo. Women expressed a favorable impression of the effectiveness of
the drug, lack of side effects, privacy of not having to come to an identified abortion facility, and
convenience. They stated a preference for a medical regimen if another abortion were needed
and would recommend it to friends.
Virtually all of the work assessing acceptability shows a strong interest in medical
methods among women requesting abortion (about two-thirds of patients). While Bachelot's study
gives some indication that women in France who come from developing countries have less
interest in this method, other information from developing countries suggests that preference for a
medical abortion method may be high there as well (Coyaji, 1990; Winikoff, et al., 1992).
In all studies, women are overwhelmingly positive about any method that safely and
effectively resolves the problem of unwanted pregnancy for them. Many authors have noted the
sense of relief that women feel at the end of abortion treatment (Tang, Urquhart and Templeton,
1988; Tang, 1991; Urquhart and Templeton, 1991; Zolese, 1991; Grimes, et al., 1992; Tang, et
al., 1993). Consistent with their great concern for solving a difficult problem, women value the
effectiveness of methods, and those women for whom a method fails are more often dissatisfied
with it. On the other hand, the technology of medical abortion has evolved to the point where
around 95% of eligible women will have a successful outcome with a medical method (Silvestre,
et al. 1990; Ulmann, et al. 1992; Peyron, et al. 1993). A 5% failure rate can have only a small
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impact on overall levels of dissatisfaction, although for any one woman the experience of failure
may be very unpleasant.
Generally, both prolonged bleeding and multiple visits may be associated with less
positive attitudes toward the technology. Similarly, the type of prostaglandin used and its side
effects will be important in the overall experience. The use of oral misoprostol, one of the newer
developments in medical abortion regimens, promises lower levels of pain and cramping than
vaginal suppositories or intramuscular prostaglandins.
One phenomenon documented in several studies (Urquhart and Templeton, 1991;
Bachelot, et al. 1992) is higher disappointment with medical abortion than surgical abortion. This
may be because the method is new and has been oversold in the press or by medical personnel
with little experience of it. As the method becomes better known, expectations may become more
realistic. On the other hand, a very small group of women may be more likely to be unhappy with
medical than with surgical abortion. Paradoxically, the medical abortion method seems to produce
greater levels of high satisfaction along with slightly greater levels of dissatisfaction. In these
studies, women who have experienced both procedures rate the medical abortion procedure
higher (Urquhart and Templeton, 1991; Legarth, et al., 1992; Thong, et al., 1992; Tang, et al.,
1993).
It is difficult to say exactly what the acceptability of medical abortion will be in clinical
practice, as this will surely be different from the study context. As one illustration of the
importance of context, Rosen (1990) interviewed non-patients as well as patients for their
preference of medical or surgical abortion. The non-patient group divided 50% to 50% about
which technology they would prefer for abortion if need be, but the patient group, currently seeking
an abortion, preferred medical abortion 74% to 26%.

IV.

Acceptability to Providers
Although patient acceptability has been discussed and studied, the issue of provider

acceptability has been much less frequently addressed. Nonetheless, it is clear that women will
not have the opportunity to choose medical abortion if the technology is rejected by providers,
program managers, and policy makers. Availability of abortion services is clearly an important
determinant of whether women will be able to use the services they desire (Richards, 1973), and if
providers reject a service it will not be offered as widely.
Clear provider preferences for different abortion technologies have been recorded. With
respect to second trimester abortion, providers seek to distance themselves from an unpleasant
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procedure: physicians prefer medical abortions (where they need not be present at the expulsion
of the fetus), and nurses prefer D & E procedures (where the physician does the "distasteful"
surgery) (Kaltreider, et al., 1979). Some have held that medical termination of pregnancy in the
second trimester is morally preferable to surgery (Lilford and Johnson, 1989). Such
considerations are less likely to be important with respect to abortion early in the first trimester. In
fact, since earlier abortions are more acceptable to professionals (Evans, et al. 1991), it may be
that a medical method that allows very early abortion (even earlier than vacuum aspiration) will be
particularly preferred by providers.
Provider attitudes toward abortion depend on many characteristics including personality
and values (Bourne, 1972a; Bourne, 1972b). Weisman, et al. (1986), have documented that
women providers tend to be more likely to provide abortion services than male providers. Thus, if
women providers share women patients' enthusiasm for medical methods, this may increase the
propensity of the provider community to make available medical alternatives to surgery.
The service delivery environment will also influence the acceptability of a new method.
Reimbursement policies of various government and insurance entities will be of interest to private
practitioners. In environments where there is harassment of abortion providers, the possibility of
providing abortion services less visibly than in a surgical clinic may be appealing. On the other
hand, the burdens of provision of information and counseling to patients may be higher with a
medical method. The anxieties of patients waiting for an abortion to take place, perhaps over a
period of days to weeks, may also place more demands on providers and may reduce their
enthusiasm for the method (Greenslade, et al., 1993).
Providers are responsive to the well-being of their patients as well as to their own practice
constraints. Thus, any method that works well and is consonant with patient safety and comfort is
of interest. When, in addition, it is obvious that many patients would prefer the method, provider
interest grows.

V.

Conclusion
Unwanted pregnancy is a serious and stressful problem for women. Technologies that

afford safe and effective abortion are very well accepted and provide relief from a great difficulty.
Many women fear surgery and will go far to avoid it. There is substantial apprehension
about general anesthesia during surgery and at the same time fear that local anesthesia may not
prevent pain. This leads to a high demand for a medical abortion alternative.
An "easy" abortion procedure is highly valued. Some women consider that the quick and
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definitive surgical alternative is easier; some find that swallowing a pill is "easier."
Privacy is greatly valued both in the sense of keeping the need and fact of abortion secret
and in the sense of preserving bodily autonomy and preventing physical exposure before
strangers. Medical abortion technology seems to meet this need more than surgical abortion,
especially if the surgical alternative mandates hospital admission and absence from home.
The high values placed on privacy, autonomy, and the wish to be able to be at home
combine, in at least some settings, to create a demand for a self-administered home treatment for
early abortion. A safe and effective regimen for such use would be acceptable and important for
many women.
Failure of an abortion method is frequently a cause for dissatisfaction, but both medical
and surgical modalities now provide such a high degree of success that this will not be the cause
of a large amount of recorded dissatisfaction. On the other hand, if a method becomes known in
the community as less reliable, it will probably be less well regarded.
Pain and gastrointestinal disturbances are clearly a problem with the use of some
prostaglandins but do not cause wholesale rejection of medical abortion using these drugs,
because other characteristics of medical abortion seem compelling to many women. Newer
medical abortion regimens using misoprostol may provide substantially more comfortable
experiences for women.
The prolonged bleeding experienced by some women using medical abortifacients is
perceived as unpleasant and inconvenient. If this could be reduced, the method would be viewed
even more favorably.
A regimen requiring many visits is likely to be less acceptable, but many women will agree
to a fair number of visits simply to have the opportunity to choose a medical alternative. Two or
three visits seem to pose no special burden to women already able to avail themselves of existing
services. On the other hand, program planners should be considerate and reduce the number of
mandated visits to the fewest possible. Improvements in technology may also be able to help with
this issue if the antiprogestin and prostaglandin can be formulated to be taken at the same time.
Given a choice between surgery and any of several medical abortion methods, most
eligible women appear to prefer the medical method. In groups studied to date, satisfaction with
the experience is extremely high. When measured against surgical procedures, women generally
report more high levels of satisfaction and willingness to use again and/or to recommend to
others. At the same time, however, the size of the small dissatisfied minority is often larger than
among surgical patients. This may be due to unrealistic expectations about a new technology or
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lack of experience in identifying or counseling women likely to be unhappy with the known
characteristics of the method. In addition, there are indications that the act of selecting an
abortion method is itself associated with increased satisfaction (Henshaw, et al., 1993).
New service delivery approaches to medical abortion can be developed that might better
serve the needs of certain women and the constraints of specific service delivery environments.
For example, the suggestion of Grimes, et al. (1992), that it may be possible to develop a
"medical menstrual regulation" regimen deserves attention. This could be especially appropriate in
certain developing countries where menstrual regulation is already a well-developed health
service.
New approaches to the delivery of the two-drug regimen might also be considered. Since
mifepristone is a very safe drug with few side effects and since problems, when they occur, are
much more likely in association with the administration of prostaglandin, it might make sense to
broaden the availability of the mifepristone while maintaining medical oversight after prostaglandin
administration. This might increase both accessibility and acceptability by allowing women to
initiate the procedure at a facility or office closer to home and complete it at a more
comprehensive health care site.
No doubt the most profound significance of the availability of safe and effective medical
abortion is choice for women in a domain where previously there was none. It is clear that many
will avail themselves of this new option. Not only is medical abortion acceptable, for some it is
markedly preferable. The task now is to improve the technology and make the service delivery
even more convenient and responsive to women's needs.
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Table 1. Studies of Acceptability of First Trimester Medical Abortion
AUTHOR/
DATE

Rosen, et
al.,
1979

PLACE

NUMBE
R
STUDIED

METHODS

Sweden

30

Vacuum aspiration
with diazepan and
cervical block

30

0.8-1.0 mg 16,16
dimethyl PGE2
vaginal suppository,
q3h x 4

18

Vacuum aspiration
with 50-60 mg 9methylene PGE2

RECRUITMENT

Patients admitted to
hospital's regular
abortion service

ALLOCATION TO
METHOD

Random

LENGTH
AMENORRHEA

≤ 56 days

TOTAL
NO.
VISITS

OTHER COMMENTS

3+

Acceptability study
only for women who
had complete
abortions with method

3+

Rosen, et
al.,
1984

Sweden

Patients admitted to
hospital's regular
abortion service

Random

≤ 49 days

2+

18
Vaginal suppository
in hospital 96h x 2

2+

17
PGE2 vaginal
suppositories at
home
Hill, et al.,
1989

England

100

Mifepristone 600 mg,
then gemeprost*
vaginal suppository
@ 48 hours

First 100 who accepted
method from women
referred for abortion

One method

≤ 63 days

5

Tang,
1991

Hong
Kong

19

Vacuum aspiration

2

Mifepristone p.o.
followed by vaginal
suppository* on day
4

Patient choice after
information on both
methods

< 49 days

23

From women requesting
abortion at a family
planning association.
Surgical patients
referred.

37

Vacuum
aspiration/general
anesthesia

Regular abortion
patients, agreed to be
interviewed.
Abortion patients offered
opportunity to try
medical abortion in a

No choice of method.
Had accepted medical
method as part of a
study.

≤ 63 days

Urquhart &
Templeton
, 1991

Scotland

54
Mifepristone p.o.
then gemeprost*

7

3

4

No women admitted
to study unless one
full term delivery prior

Legarth, et
al., 1991

Denmar
k

25

vaginal suppository

study.

Vacuum
aspiration/general
anesthesia

Patients referred for
abortion

Random

≤ 42 days

25

3

3
Mifepristone 600 mg
p.o.

Holmgren,
1992

Sweden

43
40
45

Dilatation and
vacuum aspiration;
heavy sedation
Vacuum
Aspiration/local
anesthesia
Mifepristone then
gemeprost*
vaginal suppository

*16,16 Dimethyl-trans-_2 - PGE1, methylester
Acceptability trial is really of one method

Women requesting
abortion by the specific
method used

By patient choice
within medical
guidelines. Research
environment for
medical abortion.

9-12 weeks

2

5-8 weeks

2

"very early"

7

In group 1, only
women who wished to
come for a two- week
post-procedure visit
were enrolled

Table 1 (Continued)
AUTHOR/DATE

PLACE

Bachelot, et al.,
1992

France

NUMBE
R
STUDIED
33

METHODS

Vacuum aspiration/general
anesthesia

107
251

Vacuum aspiration/local
anesthesia

RECRUITMENT

From women
presenting for early
abortion at 1 of 6
clinics in France

ALLOCATION
TO METHOD

By patient choice
within clinical
context

LENGTH
AMENORRHEA

≤ 49 days

TOTAL
NO.
VISITS

OTHER
COMMENTS

3-4

All three
methods were
freely available
without enrolling
in study. None
was an
experimental
abortion method.

3-4
4-5

Mifepristone 600 mg p.o. then
nalador 0.25, I.M. after 48 hrs
Grimes, et al.,
1992

Thong, et al.,
1992

Tang, et al.,
1993

Henshaw, et al.,
1993

U.S.A.

Scotlan
d

Hong
Kong

Scotlan
d

8

Mifepristone, 600 mg p.o.

Not applicable**

Placebo

Women with delay in
menses < 10 days.
No pregnancy test.

8

94

Mifepristone then gemeprost
suppository* at 48 hours

Referred by G.P. for
abortion

≤ 63 days

5

86

Mifepristone then misoprostol
600 mcg p.o. at 48 hours
(various doses)

Most arrived
expecting a medical
method

•Not stated in
regard to the drug
•Randomized
(ward vs. sitting
room) for location
of PG treatment

Purpose was to
study preference
for ward vs.
sitting room as
place for
abortion

99

Mifepristone 600 mg p.o. then
vaginal suppository* on day 3

Patient choice
after information
on both methods.

< 49 days

2

45

Vacuum aspiration

From women
requesting abortion
at family planning
association

Vacuum
aspiration
patients were
referred
to a hospital for
the
procedure

Women requesting
abortion eligible for
both medical and
surgical methods

Women who
agreed to be
randomized were
assigned; those
who declined
randomization
received method

73
chose

a) Mifepristone 600 mg p.o.
then
gemeprost 1 mg vaginal
suppository
b) Vacuum aspiration/general
anesthesia

< 42 days

4
4

5

≤ 63 days

Surg. =
2
Med.
=3

Half of patients
in each group
were not
pregnant

Randomization
offer preceded
offer of choice

of choice.
Winikoff, et al.,
(unpublished)

India

250

Cuba

250

a) Mifepristone 600 mg p.o.
then
misoprostol 400 mcg, p.o.
b) Vacuum aspiration/general
anesthesia

Women who came
to clinic requesting
abortion

Patients eligible
for either method
could choose the
method to use

a) Mifepristone 600 mg p.o.
then
misoprostol 400 mcg
b) Vacuum aspiration/general
anesthesia
China

300
a) Mifepristone 600 mg p.o.
then
misoprostol 400 mcg
b) Vacuum aspiration/topical
anesthesia

*16,16 Dimethyl-trans-_2 - PGE1, methylester
Acceptability trial is really of one method

**Randomization with respect to placebo

≤ 56 days

Surg.=
2
Med. =
3

Table 2. Results of Studies of Acceptability of First Trimester Medical Abortion
AUTHOR/
DATE

TYPE OF
MEDICAL
ABORTION

NUMBER
AND
ASSIGNMENT OF
PATIENTS

INTERVIEWS

ATTITUDE TO MEDICAL
ABORTION PRIOR TO
RX

POSITIVE
ASPECTS
POST-RX

NEGATIVE
ASPECTS
POST-RX

Rosen, et
al., 1979

PG vaginal
suppository

Rosen, et
al., 1984

30(R)*

a) prior to first
appointment
with M.D.
b) after treatment,
prior to
discharge
c) 2 weeks later

More favorable to medical
than surgical abortion

•better than
expected
•easier than
expected
•more harmless
than
expected

Higher
scores on
pain and
bleeding than
surgical
patients

Not
reported

PG vaginal
suppository
(hospital)

18(R)*

a) prior to first
appointment
with M.D.

Generally met
positive
expectations

Pain/bleedin
g led some to
prefer
surgical

PG vaginal
suppository
(home)

17(R)*

Preferred by 15% of
sample
Preferred by 65% of
sample
•medical abortion more
natural
•some felt safer in hospital
•home more comfortable
•home more private
•possibility of partner
support at home

64% of
those who
had
medical
abortion

Hill, 1989

Mifepriston
e & PG
vaginal
suppository

100(C/L)*

a) 7 days posttreatment
b) 14 days posttreatment
c) 28 days posttreatment

64% of those offered
method agreed to try it

95% complete
abortion

Over one half
required
analgesia
after PG

88%: yes
3%:
unsure
9%: no
·3% due
to failure
·6% due
to pain

Tang,
1991

Mifepriston
e & PG
vaginal
suppository

23(C/S)*

a) before treatment
b) 8 days posttreatment
c) 15 days posttreatment
d) 43 days posttreatment

Acceptors:
less trauma
38%
more natural
22%
felt M.D. preferred
13%

Day 8:
relieved
30%
natural
21%
safe
14%

Day 8:
doubt
complete
abortion 9%
inconvenient
visits
4%

•Yes: 91%
•No: 9%

b) 2 weeks later,
prior to
follow-up exam

WOULD
USE
AGAIN

•96% would

recommen

Urquhart
and
Templeton
, 1991

Mifepriston
e & PG
vaginal
suppository

54(C/L)*

a) 2 days before
treatment
b) 1 week after
treatment
c) 4 weeks after
treatment

fear pain in surgery
11%
Refusers:
not as effective
38%
long process/many visits
28%
surgery convenient/quick
18%
want to do abortion
quickly 16%

convenient
9%

Not reported

Liked:
•awareness of
process
•more in control
•avoiding
anesthesia
•more discreet

sad, saw
abortion
4%
Day 43:
bled too long

d to
friends

11%

More
negative
assessment
if:
•younger
•nulliparous
•needed
more
analgesic
•saw
products of

•Yes: 75%
•Previous
abortion
experience
(n=13),
77% prefer
medical

conception
*R = Random Assignment
C/L = Choice to be in study of one method

C/S = Personal choice among methods in study
C/U = Personal choice among usual clinical services

Table 2 (Continued)
AUTHOR/
DATE

TYPE OF
MEDICAL
ABORTION

NUMBER
AND
ASSIGNMENT OF
PATIENTS

INTERVIEWS

Legarth,
et al.,
1991

Mifepristone

25(R)*

1 week after
treatment

Holmgren
, 1992

Mifepristone
& PG
vaginal
suppository

45(C/L)*

Bachelot,
1992

Mifepristone
& PG, I.M.

Grimes,

Mifepristone

ATTITUDES PRIOR TO RX

POSITIVE ASPECTS
POST-RX

NEGATIVE ASPECTS
POST-RX

WOULD USE AGAIN

Not applicable

Rated acceptable by
patients classified as
"uncomplicated" cases

20% of
"uncomplicated" cases
reported side affects—
all mild

All four patients with
previous abortion
preferred medical
method

2 weeks after
treatment

Not applicable

Week 2
•positive assessment
87%
•expressed relief
40%

Week 2
•bleeding heavier than
menses
65%
•"much pain"
44%

•yes: 81%
•most women would
choose method used
this time for next time

251(C/U)*

a) day of treatment prior
to
selection of
method
b) 2 weeks after
treatment

Acceptors:
less trauma
67%
less dangerous
29%
less risk future pregnancy
27%
Refusers:
less trauma
53%
less failure
36%
less dangerous
29%
less risk future pregnancy
16%
Acceptors valued:
•newness
•efficacy
•lack of invasiveness
•possibility of verifying
expulsion
•naturalness of process

•63% wanted to see
what
had been
expelled
•large majority satisfied

•12% some
dissatisfaction
(increased with
complications or
failures)
•women felt need for
rest/ sleep after
procedure
•some found method
not so quick and
easy as
expected

16(C/L)*

4 weeks post-

•believed in efficacy

•liked privacy

Some had side effects

•generally yes

et al.,
1992

(or placebo)

Thong, et
al., 1992

Mifepristone
& PG
vaginal
suppository
Mifepristone
& oral PG

94 not
reported

86 not
reported

treatment

•preferred medical to surgical

•liked non-invasive
technique

of pain, nausea but
these were similar in
placebo group

•3 with previous
abortion preferred
medical method

At time of discharge after PG
visit

•not reported

•majority preferred
sittingroom treatment

•more pain in vaginal
suppository group

•95% would
recommend to friend

•majority came requesting
medical method

•60% of oral PG group
needed no
analgesia

•more analgesia in
vaginal
suppository group

•11 women with prior
surgery abortion
(n=41)
were satisfied

•99% were satisfied

*R = Random assignment
C/L = Choice to be in study of one method

C/S = Personal choice among methods in study
C/U = Personal choice among usual clinical services

Table 2 (Continued)
AUTHOR/
DATE

Tang, et
al., 1993

Henshaw,
et al.,
1993

TYPE OF
MEDICAL
ABORTION

Mifepristone
& PG vaginal
suppository

Mifepristone
& PG vaginal
suppository

NUMBER
AND
ASSIGNMENT OF
PATIENTS
99(C/S)*

73
choice
99
randomized

INTERVIEWS

ATTITUDES PRIOR TO RX

POSITIVE
ASPECTS POSTRX

NEGATIVE
ASPECTS POST-RX

WOULD USE
AGAIN

a) before
treatment
b) 8 days posttreatment
c) 15 days posttreatment
d) 43 days posttreatment

Acceptors:
fear of surgery
81%
convenient for work
41%
less injury to body
21%
fear of general anesthesia
11%
Refusers:
surgery quick
82%
too many visits/long procedure
69%
worry over efficacy/side effects
11%

Day 8:
relieved/felt good
28%
convenient/safe
20%
avoided surgery
12%

Day 8:
painful
11%

•yes:
85%
•no:
11%
•unsure: 4%

Day 43:
too time consuming
11%
bleeding too long
10%

70% of those
with prior
surgical abortion
felt medical was
better

a) at the time of
choice (?)
b) 2 weeks after
treatment

Agreed to random assign
(54%)
Chose medical
(20%)
fear surgery/anesthesia
59%
"more natural"
21%
surgery "too fast"
21%
want to be conscious
8%
Chose vacuum aspiration
(26%)
medical abortion "too slow"

More positive ratings
among those who
chose the procedure
than those assigned
to it

More painful than
surgery both among
those who chose and
who were assigned
to it

Would use same
method again:
Chose medical:
95%
Chose surgical:
90%
Assigned surg.:
87%
Assigned med.:
74%

40%
wanted to be unconscious
39%
fear adverse effects of medical abortion
23%
lived further from clinic

*R = Random assignment
C/L = Choice to be in study of one method

C/S = Personal choice among methods in study
C/U = Personal choice among usual clinical services
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